UK signs deal with GlaxoSmithKline & Sanofi for potential Covid-19 vaccine

UK signs deal with GlaxoSmithKline & Sanofi for potential Covid-19 vaccine

UK has signed a deal with GlaxoSmithKline & Sanofi for 60mn doses of another potential Covid-19 vaccine. UK has now secured four different types of experimental Covid-19 vaccines, giving the country access to a total of 250mn doses, enough to allow everyone in UK to have four each, if they work. Scientists have yet to begin trial on GSK/Sanofi’s vaccine on humans and studies won’t begin until Sep.

Milan
Milan
Neil
Neil 1 weeks

This is a huge game changer, I hope the science world and other drug manufacturers are watching.

Top in Business
Get the App